Test Price
2,800 AED✅ Home Collection Available
MT‑TG Gene Hypertrophic Cardiomyopathy (MT‑TG‑Related) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Sensitivity: 99.9% using targeted NGS with ISO 9001:2015 certified protocols (Certificate INT/EGQ/2509DA/3139).
- Price: 2,800 AED (inclusive of pre‑test genetic counselling and post‑test physician teleconsultation).
- Turnaround Time: 3–4 weeks from sample receipt.
- Sample Collection: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection – available daily 8 AM to 11 PM. No hospital visit required.
- Insurance Verification: Direct WhatsApp verification at +971 54 548 8731.
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) test screens for pathogenic variants in the MT‑TG gene associated with hypertrophic cardiomyopathy. It provides clinical‑grade genetic insights for diagnosis, family cascade screening, and athletic clearance. The assay uses customized capture probes targeting the entire MT‑TG gene, including deep intronic and regulatory regions, achieving an average read depth of >500× with minimum coverage of 98%.
| Feature | MT‑TG Targeted NGS (Our Test) | Whole Exome Sequencing (Alternative) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity for MT‑TG; deep coverage of regulatory regions | May miss deep intronic variants; lower depth for mitochondrial genes; higher false‑negative rate |
| Method | NGS with capture probes specific to MT‑TG | Wide exome capture; no targeted enrichment for mitochondrial DNA |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
“Genetic testing for MT‑TG provides vital risk stratification for hypertrophic cardiomyopathy. A positive result does not guarantee disease manifestation but identifies a predisposition that must be correlated with ECG, echocardiography, and family history. Pre‑test genetic counselling is mandatory, and post‑test cardiology consultation is strongly recommended before any clinical decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory on Genetic Test Interpretation
Genetic results must always be interpreted in conjunction with a patient’s full clinical picture, including cardiac imaging, family history, and current pharmacotherapy. Do not initiate, modify, or discontinue any medication based solely on genetic findings without consulting a qualified physician.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide informed consent, contraindication to venipuncture (if blood sample), or non‑availability of mandatory pre‑test genetic counselling.
- Emergency Red Flags: Sudden chest pain, unexplained syncope, or palpitations in conjunction with a family history of sudden cardiac death – proceed to the nearest emergency department immediately.
*Sample collection for this test complies with Federal Decree-Law No. 4 of 2016 on Medical Liability regarding patient consent and safety.
Patient FAQ & Clinical Guidance
1. What exactly does the MT‑TG gene test detect?
This targeted NGS test identifies pathogenic mutations in the MT‑TG gene associated with hypertrophic cardiomyopathy, enabling early intervention and family cascade screening.
2. How is the test performed and what sample is required?
A standard peripheral whole blood sample (2–5 mL in EDTA tube) or a dried blood spot (DBS) on FTA card provides sufficient DNA for complete MT‑TG gene sequencing. VIP Mobile Phlebotomy is available for home collection.
3. Is genetic counseling mandatory, and what happens after results?
Pre‑test genetic counseling is mandatory. If a pathogenic variant is found, post‑test counseling, cardiologist evaluation, and cascade testing of at‑risk relatives are strongly recommended.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring confidential handling of genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – securing digital health records and electronic results delivery.
All samples and data are processed within the UAE under strict privacy controls; no genetic data is transferred abroad without explicit patient consent.
Clinical & Logistical Metadata
| Test Name | MT‑TG Gene Hypertrophic Cardiomyopathy (MT‑TG‑Related) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Dried Blood Spot (DBS) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM to 11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) – targeted capture of MT‑TG gene with >500× average read depth |
| ICD-10-CM Code | I42.1 (Hypertrophic obstructive cardiomyopathy), I42.2 (Other hypertrophic cardiomyopathy) |
| LOINC Code | 100376-2 (MT‑TG gene mutation analysis in blood or dried blood spot by NGS) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians